Walter Birkmayer
Affiliations: | Neurochemie | Ludwig Boltzmann Gesellschaft |
Google:
"Walter Birkmayer"Mean distance: (not calculated yet)
Children
Sign in to add traineePeter Franz Riederer | research scientist | Ludwig Boltzmann Gesellschaft |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Birkmayer W, Hornykiewicz O. (2001) The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961. Wiener Klinische Wochenschrift. 113: 851-4 |
Birkmayer W, Hornykiewicz O. (1998) The effect of l-3,4-dihydroxyphenylalanine (=DOPA) on akinesia in parkinsonism. Parkinsonism & Related Disorders. 4: 59-60 |
Birkmayer GJ, Birkmayer W. (1989) Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH). Acta Neurologica Scandinavica. Supplementum. 126: 183-7 |
Birkmayer W, Birkmayer JD. (1987) Dopamine action and disorders of neurotransmitter balance. Gerontology. 33: 168-71 |
Birkmayer W, Riederer P. (1986) Biological aspects of depression in Parkinson's disease. Psychopathology. 19: 58-61 |
Birkmayer W, Knoll J, Riederer P, et al. (1985) Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study. Journal of Neural Transmission. 64: 113-27 |
Birkmayer W, Riederer P, Linauer W, et al. (1984) L-deprenyl plus L-phenylalanine in the treatment of depression. Journal of Neural Transmission. 59: 81-7 |
Birkmayer W, Riederer P. (1984) Deprenyl prolongs the therapeutic efficacy of combined L-DOPA in Parkinson's disease. Advances in Neurology. 40: 475-81 |
Birkmayer W, Birkmayer G, Lechner H, et al. (1983) DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness. Journal of Neural Transmission. 58: 305-13 |
Birkmayer W, Knoll J, Riederer P, et al. (1983) (-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease. Modern Problems of Pharmacopsychiatry. 19: 170-6 |